Key facts
- Notable investors include Changchun Huize Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Xinlitai Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Xinlitai Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xinlitai Biotechnology
Provider of biotechnology research and development services intended to advance medical innovation and experimental studies. The company offers expertise in medical research, technical development, patent-backed biotechnologies, and knowledge transfer, enabling healthcare institutions and scientific communities to pursue novel therapies and improved patient outcomes.
- Sector
- Healthcare
- HQ
- Changchun, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Xinlitai Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xinlitai Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xinlitai Biotechnology in its N-PORT filings yet. We sweep new filings monthly.